Prosecution Insights
Last updated: October 01, 2026
Application No. 18/550,880

ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOUND, AND ELECTRONIC DEVICE

Non-Final OA §102§103
Filed
Sep 15, 2023
Priority
Mar 18, 2021 — JP 2021-045119 +2 more
Examiner
NGUYEN, VU ANH
Art Unit
Tech Center
Assignee
Toray Industries Inc.
OA Round
1 (Non-Final)
83%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 83% — above average
83%
Career Allowance Rate
1272 granted / 1528 resolved
+23.2% vs TC avg
Strong +16% interview lift
Without
With
+15.9%
Interview Lift
resolved cases with interview
Typical timeline
2y 5m
Avg Prosecution
28 currently pending
Career history
1534
Total Applications
across all art units

Statute-Specific Performance

§101
1.0%
-39.0% vs TC avg
§103
40.7%
+0.7% vs TC avg
§102
27.6%
-12.4% vs TC avg
§112
27.7%
-12.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1528 resolved cases

Office Action

§102 §103
Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 28-29, 31-32, 34-35, 37-38 and 41-46 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by WO 2021/157593 A1 to Kakizoe et al. (see attached machine-generated English-language translation). Unless stated otherwise, the page numbers are in reference to the original document. Kakizoe et al. discloses an OLED having the configuration of anode/HIL/HTL/ EBL/EML/HBL/ETL/EIL/cathode (p. 78 of the translation), wherein the EML comprises a host material, a 1st TADF dopant and a 2nd TADF dopant, wherein the 2nd TADF dopant may emit light having a wavelength of 450-495 nm (p. 41). S1(host) > S1 (1st TADF dopant) > S1 (2nd TADF dopant) (p. 8). The host material is selected from a group (pp. 7+) that includes PNG media_image1.png 368 514 media_image1.png Greyscale wherein X = O or S and L can be 1,4-phenylene (p. 7). An example of the host compound is PNG media_image2.png 216 204 media_image2.png Greyscale (p. 26). This compound is representative of the compound in claim 28, and it is exemplified in the examples (p. 99). Claim 28 is therefore anticipated. So are claims 29, 31-32, 34-35, 37-38, and 41-46. Claims 28, 32-34, 37-39, 41 and 44-46 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by US 2020/0127214 A1 to Choi et al. Regarding claim 28, Choi et al. discloses an OLED having the configuration of anode/HIL/HTL/EBL/EML/HBL/ETL/EIL/cathode, wherein the EML comprises a host compound and a TADF dopant compound and wherein S1H > S1D and T1H > T1D [0110]. The host compound has a generic structure of PNG media_image3.png 230 498 media_image3.png Greyscale , which is exemplified by such compounds as PNG media_image4.png 400 444 media_image4.png Greyscale and PNG media_image5.png 394 438 media_image5.png Greyscale (pp. 11 & 14). These host compounds are representative of the compound M3 and the corresponding devices are therefore representative of the claimed device. Claim 28 is accordingly unpatentable. See MPEP § 2131.02(II). So are claims 32-34, 37-39, 41 and 44-45. The features of claim 46 are disclosed at paragraph [0117]. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 30, 40 and 47 are rejected under 35 U.S.C. 103 as being unpatentable over WO 2021/157593 A1 to Kakizoe et al. The device of claim 28 is disclosed by Kakizoe et al. as explained above. Regarding claim 30, the prior art host compound can have L being a 1,4-phenylene as mentioned. While a device comprising host compound similar to the cited compound 21 wherein the linker is a 1,4-phenylene is not provided as an example, it would have been obvious to a person of ordinary skill in the art at the time the instant invention was filed to make and use such a device without expecting any difficulty or an unfavorable outcome. Claim 30 is therefore unpatentable. See MPEP § 2143(I)(B). Regarding claim 47, Kakizoe et al. does provide an example of a device wherein the EML comprises compounds 20, T58 and T80 as the host, the 1st dopant and the 2nd dopant, respectively (see durability test of blue light emitting element 2 on page 99). The 2nd dopant T80, PNG media_image6.png 266 270 media_image6.png Greyscale , is representative of the compound of formula 2A. While the host compound, 20, in the example is different from the claimed compound of formula 1, it would have been obvious to a person of ordinary skill in the art at the time the instant invention was filed to replace it with compound 21 and expect the same result. Regarding claim 40, Kakizoe et al. fails to disclose the host compound. However, from the fact that the group X in the generic formula can be O or S, one of ordinary skill in the art would draw a conclusion that replacing the oxygen atoms in the compound 21 with sulfur atoms would not jeopardize the performance of the device at all. Claims 28-29, 34-39 and 41-45 are rejected under 35 U.S.C. 103 as being unpatentable over US 2017/0047526 A1 to Chung et al. Chung et al. discloses an OLED having the configuration of anode/HIL/HTL/EBL/ EML/HBL/ETL/EIL/cathode, wherein the EML comprises a TADF dopant and a host material (p. 76) having a high singlet energy level and a high triplet energy level and typified by PNG media_image7.png 330 406 media_image7.png Greyscale (p. 75). This compound is representative of the compound of formula 1: n = 1, one R100 = CN, Y1 = O, R27 = CN, A = (11E) where X1 = S. As the compound serves as the host material in the EML, it must have a singlet energy S1 higher than that of the dopant. While Chung et al. fails to provide an example wherein the dopant is a TADF compound, it would have been obvious to a person of ordinary skill in the art at the time the instant invention was filed to make and use such device without expecting any difficulty or an unfavorable outcome. Claim 28 is therefore unpatentable. See MPEP § 2143(I)(B). So are claims 29, 34-35, 39 and 42-45. The features of claim 36 can be found on page 74. Those of claims 37-38 and 41 can be found on page 72. Allowable Subject Matter Claim 48 is allowed. The following is a statement of reasons for the indication of allowable subject matter: The compound of claim 48 is not disclosed or suggested by the prior art of record. Contact Information Any inquiry concerning this communication or earlier communications from the examiner should be directed to VU ANH NGUYEN whose telephone number is (571)270-5454. The examiner can normally be reached M-F 8:00 AM-5:00 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, ROBERT JONES can be reached at (571) 270-7733. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /VU A NGUYEN/Primary Examiner, Art Unit 1762
Read full office action

Prosecution Timeline

Sep 15, 2023
Application Filed
Sep 05, 2025
Response after Non-Final Action
Aug 10, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12751203
HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL
3y 10m to grant Granted Sep 29, 2026
Patent 12745555
DISPLAY ELEMENT
3y 6m to grant Granted Sep 22, 2026
Patent 12740225
LIGHT-EMITTING ELEMENT AND DISPLAY DEVICE
3y 10m to grant Granted Sep 15, 2026
Patent 12735438
ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES
3y 7m to grant Granted Sep 15, 2026
Patent 12735407
COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF
2y 9m to grant Granted Sep 15, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
83%
Grant Probability
99%
With Interview (+15.9%)
2y 5m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1528 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month